MIT Technology Review’s What’s Next series looks across industries, trends, and technologies to give you a first look at the future. You can read the rest of them here. In the final weeks of 2025, the battle over regulating artificial intelligence in the US reached a boiling point. On December 11, after Congress failed twice…
Alex Blackwood was working as a real estate investing associate at Goldman Sachs. Here’s why he decided to start a business instead — despite the pay cut.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new company, called Preventive, is being formed to research so-called “heritable genome editing,” in which the DNA of embryos would be…
Founders seeking to maximize their returns from an eventual sale should be aware of the Startup Exit Waterfall and its implications for their exit strategy.